- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04723498
Problematic Use of the Internet in Child and Adolescent Psychiatry
May 12, 2025 updated by: Susanne Walitza
Pathological internet use is a blanket term for problematic behavior types (e.g.
uncontrolled gaming, cyber pornography, cyber mobbing and excessive use of social media): all perpetrated through the internet.
There is little documentation or research on interdependencies/interplay between problematic internet and/or media use and child-adolescent disturbances.
Very few clinical examples of syndromes like attention deficiency/hyperactivity (ADHS), anxiety disorder or affective disturbances associated with pathological media/internet use, or gaming, are found in literature.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Renate Drechsler, Prof. Dr. phil.
- Phone Number: +41 43 499 4050
- Email: renate.drechsler@kjpd.uzh.ch
Study Contact Backup
- Name: Susanne Walitza, Prof. Dr. med. Dipl.-Psych.
- Phone Number: +41 43 499 26 26
- Email: susanne.walitza@puk.zh.ch
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8032
- Recruiting
- Psychiatric University Clinics, Department of Child and Adolescent Psychiatry
-
Contact:
- Renate Drechsler, Prof. Dr. phil.
- Phone Number: +41 43 499 4050
- Email: renate.drechsler@kjpd.uzh.ch
-
Contact:
- Susanne Walitza, susanne.walitza@puk.zh.ch
- Phone Number: +41 43 499 26 26
- Email: susanne.walitza@puk.zh.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- male and female patients ages from 8 - 18 years
- All study participants or their legal representative have given written permission for their experiences to be documented in the study.
Exclusion Criteria:
- Inability to understand explanations and the questionnaire, whether linguistic or cognitative
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Patients
male and female patients, handled on an ambulatory basis in Psychiatric University Clinics, Department of Child and Adolescent Psychiatrythe ages from 8 - 18 years during the study
|
Fill in screening questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptoms severity of problematic internet and media use
Time Frame: 3 months
|
The clinician screening questionnaire (PUI) contains 9 items designed to assess severity of problematic internet and media use of obsessive and compulsive in children and adolescents.The test uses a 4-point scale to rate severity of problematic internet and media use.
Higher score means a worse outcome.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Susanne Walitza, Prof. Dr. med. Dipl.-Psych., Sponsor GmbH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2020
Primary Completion (Estimated)
March 1, 2026
Study Completion (Estimated)
March 1, 2026
Study Registration Dates
First Submitted
January 21, 2021
First Submitted That Met QC Criteria
January 21, 2021
First Posted (Actual)
January 25, 2021
Study Record Updates
Last Update Posted (Actual)
May 13, 2025
Last Update Submitted That Met QC Criteria
May 12, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KJPP 2020-00117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
Clinical Trials on screening questionnaire
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
University College, LondonMedical Research Council; Cancer Research UK; National Institute for Health Research... and other collaboratorsCompleted
-
University Hospital, GrenobleClinique des Cèdres, EchirollesNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Spondylarthritis | Ulcerative Colitis | Spondylitis, AnkylosingFrance
-
University of OxfordUniversity College DublinRecruiting
-
Gazi UniversityCompleted
-
Markus J. ErnstCompletedMigraine | Tension-Type HeadacheSwitzerland
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingScreening Breast MRI in Patients Who Are BRCA Mutation CarriersUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...WithdrawnDisordered EatingUnited Kingdom
-
Lithuanian University of Health SciencesKlaipėda UniversityCompletedDysphagia | Lingual Tonsil HypertrophyLithuania